The Medical Retina Center

Filter Your Results




Pharmacologic Treatment of PDR and DME

The Diabetic Retinopathy Clinical Research Network (, formed in 2002, comprises approximately 400 ophthalm…

Stephen G. Schwartz, MD, MBA, and Ingrid U. Scott, MD, MPH

Diffuse Choroidal Hemangioma Treated With Low-Dose Plaque Br…

Choroidal hemangioma is a vascular hamartoma that generally manifests in

Lara Queirós, MD; Kareem Sioufi, MD; and Carol L. Shields, MD

Recapping the Past 12 Months

We are at the tail end of another successful year for the retina world. It is pretty amazing that one area of the eye ca…

the staff of Retina Today

Intravitreal Chemotherapy for Vitreous Seeding Caused by Ret…

Vitreous seeding is one of the primary reasons for treatment failure fo

Hilary M. Gray, BA; Kareem Sioufi, MD; and Carol L. Shields, MD

Assessing Uveitis: Beyond Vitreous Haze

The presentations of uveitis are as varied as the brands of artificial tears at your local drug store. A case of pan…

Sarju Patel, MD, MPH, MSC, and Debra Anne Goldstein, MD

A New Option for Treatment of Noninfectious Uveitis

Adalimumab (Humira, AbbVie) is a fully human monoclonal immunoglobulin G 1 (IgG1) tumor necrosis factor alpha (TNF-&…

Stephanie B. Engelhard, BA, and Ashvini K. Reddy, MD

Gene Therapy in a Drop

Age-related macular degeneration (AMD) and proliferative diabetic retinopathy (PDR) are sight-threatening diseases w…

Kuan Jiang and Gang Wei, PhD, with editorial commentary from Szilárd Kiss, MD

Adalimumab in Patients With Active and Inactive Noninfectiou…

The effectiveness of adalimumab (Humira, AbbVie) for noninfectious intermediate, posterior, and panuveitis -- that is, f…

Eric B. Suhler, MD, MPH, and Thomas Albini, MD


This Month's Supplements


Contact Info

Bryn Mawr Communications LLC
1008 Upper Gulph Road, Suite 200
Wayne, PA 19087

Phone: 484-581-1800
Fax: 484-581-1818

Karen Roman

Janet Burk

About Retina Today

Retina Today is a publication that delivers the latest research and clinical developments from areas such as medical retina, retinal surgery, vitreous, diabetes, retinal imaging, posterior segment oncology and ocular trauma. Each issue provides insight from well-respected specialists on cutting-edge therapies and surgical techniques that are currently in use and on the horizon.